<DOC>
	<DOCNO>NCT00136019</DOCNO>
	<brief_summary>Male female patient 16 70 year age diagnose epilepsy partial seizure take 3 medication medical condition take part research study approximately 85 different location United States . The purpose study evaluate effectiveness , safety tolerability consistent dosage study drug ( lacosamide [ SPM 927 ] ) take orally twice day five month . Each patient qualify choose participate study receive placebo ( inactive drug ) gradually increase dos lacosamide target dose 400mg/day 600mg/day . The target dose placebo maintain 12 week . The study clinic visit include medical history physical exam , electrocardiogram ( ECG ) , blood urine sample collection , completion seizure diary . Patients complete study may enroll extension trial receive active study drug .</brief_summary>
	<brief_title>SPM 927 ( 400mg/Day 600mg/Day ) Adjunctive Therapy Subjects With Partial Seizures With Without Secondary Generalization</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Epilepsy partial seizure Subject receive SPM 927 previous trial</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Epilepsy partial seizure</keyword>
</DOC>